Brain gyrification in bipolar disorder: a systematic review of neuroimaging studies.

Bipolar disorder Gyrification Mania Neurodevelopmental disorders Systematic review

Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Dec 2022
Historique:
accepted: 04 08 2022
pubmed: 31 8 2022
medline: 3 12 2022
entrez: 30 8 2022
Statut: ppublish

Résumé

Bipolar disorder (BD) is a severe mental illness with a strong genetic component. Genetic variations have been involved in the risk of this disorder, including those mediating brain function and neurodevelopment. Early neurodevelopment and neuroprogression processes could be reflected in brain gyrification patterns and help optimize the prediction and diagnosis of such disorders that is often delayed. Previous neuroimaging studies using this measure in patients with bipolar disorder revealed controversial results. This systematic review aimed to summarize available neuroimaging investigations on gyrification in BD compared to healthy controls (HC) and/or other psychiatric groups. Fourteen studies including 733 patients with BD, 585 patients with schizophrenia (SCZ), 90 with schizoaffective disorder (SZA), and 1380 healthy subjects were identified. Overall, a heterogeneous pattern of gyrification emerged between patients with BD and HC. Interestingly, increased gyrification or no differences were also observed in patients with BD compared to those with the schizophrenia-spectrum disorders. Furthermore, relatives of patients with BD showed lower or no differences in gyrification compared to healthy subjects without a family history of affective illness. Differences in the design and in methodological approaches could have contributed to the heterogeneity of the findings. The current review supports an altered brain gyrification pattern that underlies the pathophysiology of BD spanning large anatomical and functional neural networks, associated with altered cognitive functioning, difficulties in processing and affective regulation, and clinical symptoms. Longitudinal studies are needed to test different bipolar phenotypes and pharmacological effects on gyrification.

Identifiants

pubmed: 36042153
doi: 10.1007/s11682-022-00713-x
pii: 10.1007/s11682-022-00713-x
pmc: PMC9712346
doi:

Types de publication

Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2768-2784

Informations de copyright

© 2022. The Author(s).

Références

J Affect Disord. 2015 Oct 1;185:104-7
pubmed: 26160154
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Nat Commun. 2019 Nov 15;10(1):5192
pubmed: 31729356
Curr Psychiatry Rep. 2018 May 7;20(5):36
pubmed: 29732528
Bipolar Disord. 2019 May;21(3):215-227
pubmed: 30444299
Brain Cogn. 2010 Feb;72(1):36-45
pubmed: 19942335
Biol Psychiatry. 2017 Nov 15;82(10):737-745
pubmed: 28709499
J Affect Disord. 2022 Sep 15;313:222-231
pubmed: 35780966
FEBS Lett. 2019 Jul;593(13):1654-1674
pubmed: 31218672
Bipolar Disord. 2010 Jun;12(4):404-13
pubmed: 20636638
Curr Neuropharmacol. 2012 Sep;10(3):239-53
pubmed: 23449817
Am J Psychiatry. 2001 Mar;158(3):420-6
pubmed: 11229983
Neuroimage Clin. 2020;25:102131
pubmed: 31911343
Psychiatry Res. 2016 Feb 28;236:173-178
pubmed: 26775167
BMJ. 2012 Dec 27;345:e8508
pubmed: 23271744
Sci Rep. 2017 Mar 30;7(1):511
pubmed: 28360420
Schizophr Bull. 2014 Mar;40 Suppl 2:S138-46
pubmed: 24371326
Biol Psychiatry. 2009 Aug 1;66(3):293-7
pubmed: 19167700
Cereb Cortex. 2008 Oct;18(10):2352-7
pubmed: 18267953
N Engl J Med. 2020 Jul 2;383(1):58-66
pubmed: 32609982
Dev Psychopathol. 2011 Feb;23(1):339-52
pubmed: 21262059
Cogn Neuropsychiatry. 2013;18(1-2):129-45
pubmed: 23137046
J Affect Disord. 2016 May;195:199-214
pubmed: 26896814
Psychol Med. 2013 Jan;43(1):119-31
pubmed: 22575089
Nat Rev Genet. 2012 Jul 10;13(8):537-51
pubmed: 22777127
Mol Psychiatry. 2020 Mar;25(3):544-559
pubmed: 31907381
Curr Drug Metab. 2018;19(8):663-673
pubmed: 29283064
Acta Psychiatr Scand. 2017 Jun;135(6):612-613
pubmed: 28430365
Am J Psychiatry. 2014 May;171(5):557-63
pubmed: 24480930
Bipolar Disord. 2017 Mar;19(2):84-96
pubmed: 28470927
Psychol Med. 2008 Aug;38(8):1133-40
pubmed: 17988422
Cereb Cortex. 1999 Mar;9(2):151-60
pubmed: 10220227
Psychol Med. 2022 Sep;52(12):2232-2244
pubmed: 33190651
Anat Embryol (Berl). 1988;179(2):173-9
pubmed: 3232854
Biol Psychiatry. 2014 Sep 15;76(6):447-55
pubmed: 24369266
Br J Psychiatry. 1999 Feb;174:121-7
pubmed: 10211165
Bipolar Disord. 2000 Sep;2(3 Pt 1):148-64
pubmed: 11256682
JAMA Psychiatry. 2013 Oct;70(10):1031-40
pubmed: 23945954
Transl Psychiatry. 2021 Mar 17;11(1):176
pubmed: 33731700
Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:3933-6
pubmed: 19163573
IEEE Trans Med Imaging. 2008 Feb;27(2):161-70
pubmed: 18334438
Biol Psychiatry. 2022 Sep 1;92(5):375-384
pubmed: 35523593
Epidemiol Psychiatr Sci. 2022 Feb 03;31:e12
pubmed: 35109957
EBioMedicine. 2015 Sep 08;2(10):1405-19
pubmed: 26629535
Neuroimage Clin. 2020;26:102220
pubmed: 32146321
Nature. 1997 Jan 23;385(6614):313-8
pubmed: 9002514
Clin Psychopharmacol Neurosci. 2017 May 31;15(2):100-114
pubmed: 28449557
Schizophr Bull. 2017 Oct 21;43(6):1176-1189
pubmed: 29045744
Schizophr Res. 2013 Jun;147(1):39-45
pubmed: 23602598
J Affect Disord. 2018 Mar 15;229:125-134
pubmed: 29306692
J Affect Disord. 2013 Jun;148(2-3):161-9
pubmed: 23477848
Hum Brain Mapp. 2017 Feb;38(2):631-643
pubmed: 27623046
Neuroimage. 2006 Aug 1;32(1):180-94
pubmed: 16651008
Acta Psychiatr Scand. 2009 Mar;119(3):192-8
pubmed: 19032702
Schizophr Res. 2013 Aug;148(1-3):74-80
pubmed: 23727217
Biol Psychiatry. 2018 Nov 1;84(9):692-701
pubmed: 29910027
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Oct 1;32(7):1617-27
pubmed: 18538910
Psychol Med. 2019 Jun;49(8):1308-1315
pubmed: 30058502
J Affect Disord. 2019 Jun 15;253:35-43
pubmed: 31022627
Acta Psychiatr Scand. 2007 Dec;116(6):467-72
pubmed: 17997725
Bipolar Disord. 2015 Mar;17(2):212-23
pubmed: 25130321
J Affect Disord. 2022 Jan 15;297:169-175
pubmed: 34699849
J Psychiatr Res. 2016 Jan;72:22-9
pubmed: 26519766
Psychiatry Res. 2014 Aug 15;218(1-2):54-60
pubmed: 24793757
Arch Gen Psychiatry. 2002 May;59(5):449-56
pubmed: 11982449
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jan 10;88:112-120
pubmed: 30017778
PLoS Comput Biol. 2010 Apr 22;6(4):e1000749
pubmed: 20421989
Schizophr Bull. 2014 May;40(3):675-84
pubmed: 23615812
Cereb Cortex. 2005 Dec;15(12):1900-13
pubmed: 15758198
Mol Neuropsychiatry. 2018 Jun;4(1):30-34
pubmed: 29998116
Schizophr Res. 2014 Sep;158(1-3):91-9
pubmed: 25085384
Mol Cell Neurosci. 2016 Jun;73:63-83
pubmed: 26608002
Transl Psychiatry. 2021 Oct 23;11(1):547
pubmed: 34689161
Neuropsychobiology. 2016;74(3):159-168
pubmed: 28494468

Auteurs

Alessandro Miola (A)

Department of Neuroscience (DNS), University of Padova, via Belzoni 160, I-35121, Padua, Italy.
Padua Neuroscience Center, University of Padova, Padua, Italy.

Giulia Cattarinussi (G)

Department of Neuroscience (DNS), University of Padova, via Belzoni 160, I-35121, Padua, Italy.
Padua Neuroscience Center, University of Padova, Padua, Italy.

Maria Lavinia Loré (ML)

Department of Neuroscience (DNS), University of Padova, via Belzoni 160, I-35121, Padua, Italy.

Niccolò Ghiotto (N)

Department of Neuroscience (DNS), University of Padova, via Belzoni 160, I-35121, Padua, Italy.

Enrico Collantoni (E)

Department of Neuroscience (DNS), University of Padova, via Belzoni 160, I-35121, Padua, Italy.
Padua Neuroscience Center, University of Padova, Padua, Italy.

Fabio Sambataro (F)

Department of Neuroscience (DNS), University of Padova, via Belzoni 160, I-35121, Padua, Italy. fabio.sambataro@unipd.it.
Padua Neuroscience Center, University of Padova, Padua, Italy. fabio.sambataro@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH